R
Robert Deziel
Researcher at Boehringer Ingelheim
Publications - 87
Citations - 2254
Robert Deziel is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Histone deacetylase & Alkyl. The author has an hindex of 30, co-authored 87 publications receiving 2200 citations.
Papers
More filters
Journal ArticleDOI
A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo
Michel Liuzzi,Robert Deziel,Nell Moss,Pierre L. Beaulieu,Anne-Marie Bonneau,Christiane Bousquet,James G. Chafouleas,Michel Garneau,Jorge Jaramillo,Richard Krogsrud,Lisette Lagacé,Robert S. McCollum,Sopone Nawoot,Yvan Guindon +13 more
TL;DR: BILD 1263 is reported on, which to the authors' knowledge is the first HSV RNR subunit-association inhibitor with antiviral activity in vivo and may lead to the design of new strategies to treat herpesvirus infections in humans.
Journal ArticleDOI
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease
Montse Llinas-Brunet,Murray D. Bailey,Robert Deziel,Gulrez Fazal,Vida Gorys,Sylvie Goulet,Ted Halmos,Roger Maurice,Martin Poirier,Marc-André Poupart,Jean Rancourt,Diane Thibeault,Dominik Wernic,Daniel Lamarre +13 more
TL;DR: Norvaline was identified as a chemically stable replacement for the P1 residue of Ac-DDIVPC-OH which was also compatible with activated carbonyl functionalities.
Journal ArticleDOI
Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors
David Smil,Sukhdev Manku,Yves Andre Chantigny,Silvana Leit,Amal Wahhab,Theresa P. Yan,Marielle Fournel,Christiane R. Maroun,Zuomei Li,Anne-Marie Lemieux,Alina Nicolescu,Jubrail Rahil,Sylvain Lefebvre,Anthony Panetta,Jeffrey M. Besterman,Robert Deziel +15 more
TL;DR: Novel, chiral 3,4-dihydroquinoxalin-2(1H)-one and piperazine-2,5-dione aryl hydroxamates showing selectivity (up to 40-fold) for human HDAC6 over other class I/IIa HDACs suggests new possibilities for use of chiral compounds in selective HDAC isoform inhibition.
Journal ArticleDOI
N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).
Martin Allan,Sukhdev Manku,Eric Therrien,Natalie Nguyen,Sylvia Styhler,Marie-France Robert,Anne-Christine Goulet,Andrea J. Petschner,Gabi Rahil,A. Robert MacLeod,Robert Deziel,Jeffrey M. Besterman,Hannah Nguyen,Amal Wahhab +13 more
TL;DR: A series of N-benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides targeting co-activator associated arginine methyltransferase 1 (CARM1) have been designed and synthesized with the thiophene analogues being superior to thiazole, pyridine, isoindoline and benzofuran based inhibitors.
Journal ArticleDOI
β-Lactam derivatives as inhibitors of human cytomegalovirus protease
Christiane Yoakim,William W. Ogilvie,Dale R. Cameron,Catherine Chabot,Ingrid Guse,Bruno Haché,Julie Naud,Jeff A. O'Meara,Raymond Plante,Robert Deziel +9 more
TL;DR: The use of both tri- and tetrasubstituted urea functionalities gave effective inhibitors of HCMV protease, and Benzyl substitution of the urea moiety was beneficial, especially when strong electron-withdrawing groups where attached at the para position.